Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

Histone Deacetylases as Targets of Cancer Therapy (Basic Science-Clinical Interface Session: Pathways to Progress)

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3
HDACs: An overview
Chairperson: Dr. Edward Seto
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
from AACR 100th Annual Meeting 2009 on April 18, 2009 8:00 AM-10:00 AM
Development of histone deacetylase inhibitors as cancer therapeutics
Ricky W. Johnstone, Ph.D.
Peter MacCallum Cancer Institute, East Melbourne, Australia
from AACR 100th Annual Meeting 2009 on April 18, 2009 8:00 AM-10:00 AM
Vorinostat: Preclinical and clinical experience
Christian Steinkuhler, Ph.D.
Merck and Co., Pomezia, Italy
from AACR 100th Annual Meeting 2009 on April 18, 2009 8:00 AM-10:00 AM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 3 of 3